Articles published by Enveric Biosciences
![](https://mms.businesswire.com/media/20240529455789/en/2145271/22/Enveric_logo.jpg)
![](https://mms.businesswire.com/media/20240514374351/en/2131630/22/Enveric_logo.jpg)
![](https://mms.businesswire.com/media/20240514809396/en/2129050/22/Enveric.jpg)
![](https://mms.businesswire.com/media/20240508099100/en/2123993/22/Enveric.jpg)
![](https://mms.businesswire.com/media/20240326297550/en/2080198/22/Enveric_logo.jpg)
![](https://mms.businesswire.com/media/20240318068312/en/2071967/22/Enveric_logo.jpg)
![](https://mms.businesswire.com/media/20240311029002/en/2063553/22/Enveric_logo.jpg)
![](https://mms.businesswire.com/media/20240228697980/en/2049712/22/Enveric_logo.jpg)
![](https://mms.businesswire.com/media/20240222887102/en/2043384/22/Enveric_logo.jpg)
Enveric Biosciences Agrees to Sell Cancer-Targeting Cannabinoid-Related Intellectual Property
February 23, 2024
From Enveric Biosciences
Via Business Wire
Tickers
ENVB
![](https://mms.businesswire.com/media/20240221498747/en/2039758/22/Enveric.jpg)
![](https://mms.businesswire.com/media/20240103821215/en/1986545/22/Enveric.jpg)
Enveric Biosciences Updates Key Data Underpinning Selection of EB-003 as Lead Drug Candidate from EVM301 Series
January 03, 2024
From Enveric Biosciences
Via Business Wire
Tickers
ENVB
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20231228071292/en/1981568/22/Enveric.jpg)
![](https://mms.businesswire.com/media/20231227487990/en/1980494/22/Enveric.jpg)
Enveric Biosciences Reports Year End Progress for Preclinical Development of Lead Prodrug Candidate EB-373
December 27, 2023
From Enveric Biosciences
Via Business Wire
Tickers
ENVB
![](https://mms.businesswire.com/media/20231220008475/en/1975196/22/Enveric.jpg)
Enveric Biosciences to Participate in Biotech Showcase 2024 During “J.P. Morgan Week 2024”
December 20, 2023
From Enveric Biosciences
Via Business Wire
Tickers
ENVB
![](https://mms.businesswire.com/media/20231205577387/en/1960416/22/Enveric_logo.jpg)
![](https://mms.businesswire.com/media/20231128128606/en/1954928/22/Enveric_logo.jpg)
Enveric Biosciences Receives Notice of Allowance from USPTO for Development of Glycosylated Psilocybin Derivatives
November 29, 2023
From Enveric Biosciences
Via Business Wire
Tickers
ENVB
![](https://mms.businesswire.com/media/20231126422057/en/1952611/22/Enveric_logo.jpg)
![](https://mms.businesswire.com/media/20231123642251/en/1952144/22/Enveric_logo.jpg)
Enveric Biosciences Announces Presentation of Two Posters at Canadian Chemical Engineering Conference (CSChE 2023)
November 24, 2023
From Enveric Biosciences
Via Business Wire
Tickers
ENVB
![](https://mms.businesswire.com/media/20231020004309/en/1921129/22/Enveric_logo.jpg)
![](https://mms.businesswire.com/media/20231018687850/en/1918691/22/Enveric_logo.jpg)
![](https://mms.businesswire.com/media/20231011016406/en/1912520/22/Enveric_logo.jpg)
Enveric Biosciences Announces Two Poster Presentations at the 6th Neuropsychiatric Drug Development Summit
October 11, 2023
From Enveric Biosciences
Via Business Wire
Tickers
ENVB
![](https://mms.businesswire.com/media/20231002875613/en/1905190/22/Enveric_logo.jpg)
![](https://mms.businesswire.com/media/20230927944915/en/1900488/22/Enveric_logo.jpg)
![](https://mms.businesswire.com/media/20230919983290/en/1894959/22/Enveric_logo.jpg)
![](https://mms.businesswire.com/media/20230918207366/en/1891988/22/Enveric.jpg)
![](https://mms.businesswire.com/media/20230911505474/en/1885884/22/Enveric.jpg)
![](https://mms.businesswire.com/media/20230904661205/en/1881008/22/Enveric_logo.jpg)
Enveric Biosciences Announces New U.S. Patent for C4-Carboxylic Acid-Substituted Tryptamine Derivatives
September 05, 2023
From Enveric Biosciences
Via Business Wire
Tickers
ENVB
![](https://mms.businesswire.com/media/20230830661319/en/1877992/22/Enveric_logo.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.